KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Asset Utilization Ratio (2016 - 2026)

West Pharmaceutical Services has reported Asset Utilization Ratio over the past 17 years, most recently at 0.77 for Q1 2026.

  • Quarterly Asset Utilization Ratio fell 3.61% to 0.77 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.77 through Mar 2026, down 3.61% year-over-year, with the annual reading at 0.78 for FY2025, 0.34% changed from the prior year.
  • Asset Utilization Ratio was 0.77 for Q1 2026 at West Pharmaceutical Services, up from 0.73 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.88 in Q2 2022 and troughed at 0.73 in Q4 2025.
  • The 5-year median for Asset Utilization Ratio is 0.79 (2023), against an average of 0.8.
  • Biggest five-year swings in Asset Utilization Ratio: decreased 11.89% in 2023 and later grew 4.65% in 2024.
  • Tracing WST's Asset Utilization Ratio over 5 years: stood at 0.83 in 2022, then dropped by 6.59% to 0.78 in 2023, then rose by 1.64% to 0.79 in 2024, then decreased by 7.16% to 0.73 in 2025, then grew by 4.73% to 0.77 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.77, 0.73, and 0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.